| |
Investors
Business Objective
Avanti NanoSciences overall strategy is to build a portfolio of
unique bionanotechnology applications in the important areas of
accelerated drug development, healthcare, clinical biomarkers
monitoring, molecular diagnostics, industrial microbiology, food
safety and bio defense with a foundation built on innovative
NanoBindi platform. With a uniquely broad portfolio of products,
Avanti NanoSciences will supply a wide array of innovative products
and services to life science and health care professionals
worldwide.
Financial path to Success
With Avanti NanoScience's focus on its key biopharmaceutical
domain and the creation of strategic development partnerships, the
company expects its market share and profits to steadily increase.
Avanti NanoScience’s management team has more than 100 years of
professional experience. Company is seeking $ 6 million in
investment. Avanti NanoSciences expects to be cash flow positive in
year 2 of operations.
Considering company’s knowledge based resources, company will
achieve and maintain sustainable competitive advantage by
continuously developing existing and creating new resources and
capabilities in response to rapidly evolving market conditions.
Company’s knowledge base and innovative thinking represent our most
important value-creating asset. Our distinctive strengths in terms
of IP estate, effective leadership, teamwork and tacit knowledge of
the domain supported by the investor groups reproducible
capabilities of finance and financial markets will enable the
company to achieve and maintain the leadership position in this fast
growing life science market segment.
Management team is in the process of negotiating with potential
investors for the investment needed to start the business. A total
of $ 6 million dollars in investment is needed to operate the
company for next three years.
|
|
For Investment Inquiries
Contact:
Arkesh Mehta, CEO
IR@at-gc.com
|
